Healthcare -
Biotechnology - NASDAQ - US
$ 8.3
0.606 %
$ 410 M
Market Cap
-2.26
P/E
KALV - NET INCOME
Net Income KALV - KalVista Pharmaceuticals, Inc.
-127 M
LAST VALUE
-24.02%
2 YEAR CAGR
-43.50%
5 YEAR CAGR
-36.41%
10 YEAR CAGR